Fingerprint
Dive into the research topics of 'A phase II trial of human recombinant lnterleukin‐2 administered as a 4‐day continuous infusion for children with refractory neuroblastoma, non‐Hodgkin's lymphoma, sarcoma, renal cell carcinoma, and malignant melanoma. A childrens cancer group study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically